Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Der Nervenarzt|July 2, 2024
[(Auto)immunity in focal epilepsy: mechanisms of (auto‑)immune-inflammatory epileptogenic neurodegeneration]Nico Melzer, Katharina Weber, Saskia Räuber, et al.
International Journal of Molecular Sciences|April 17, 2025
Do Nitrosative Stress Molecules Hold Promise as Biomarkers for Multiple Sclerosis?Moritz Förster, Saskia Räuber, Philipp Albrecht, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 15, 2022
Social interaction, psychotic disorders and inflammation: A triangle of interestTimo Jendrik Faustmann, Daniel Kamp, Saskia Räuber, et al.
Vaccines|July 27, 2022
Neuromyotonia with Central Nervous System Lesions following Quadrivalent Human Papilloma Virus VaccinationMaryam Hatami, Moritz Förster, Vivien Weyers, et al.
European Journal of Immunology|August 8, 2020
Differential MHC-II expression and phagocytic functions of embryo-derived cardiac macrophages in the course of myocardial infarction in miceTobias Weinberger, Saskia Räuber, Vanessa Schneider, et al.
Digital Health|February 10, 2023
Driving time-based identification of gaps in specialised care coverage: An example of neuroinflammatory diseases in GermanyLars Masanneck, Saskia Räuber, Christina B Schroeter, et al.
Biomedicines|June 24, 2022
Modulation of <i>Rxr</i>α Expression in Mononuclear Phagocytes Impacts on Cardiac Remodeling after Ischemia-Reperfusion InjurySaskia Räuber, Maximilian Fischer, Denise Messerer, et al.
Journal of Clinical Immunology|April 12, 2021
The Innate Immune Response Characterizes Posterior Reversible Encephalopathy SyndromeChristopher Nelke, Andreas Schulte-Mecklenbeck, Marc Pawlitzki, et al.
Biomedicines|December 24, 2021
Nitrosative Stress Molecules in Multiple Sclerosis: A Meta-AnalysisMoritz Förster, Christopher Nelke, Saskia Räuber, et al.
Multiple Sclerosis and Related Disorders|February 12, 2022
A national, multi-center study in Germany to assess implementation of infusion management, treatment satisfaction and quality of life in MS patients receiving alemtuzumabSaskia Räuber, Marc Pawlitzki, Melanie Korsen, et al.
Pageof 5